LYELL LYFE MANUFACTURING CENTER Trademark

Trademark Overview


On Monday, March 15, 2021, a trademark application was filed for LYELL LYFE MANUFACTURING CENTER with the United States Patent and Trademark Office. The USPTO has given the LYELL LYFE MANUFACTURING CENTER trademark a serial number of 90580477. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, December 18, 2023. This trademark is owned by Lyell Immunopharma, Inc.. The LYELL LYFE MANUFACTURING CENTER trademark is filed in the Treatment & Processing of Materials Services and Computer & Software Services & Scientific Services categories with the following description:

Custom manufacture of pharmaceuticals

Pharmaceutical research and development; development of pharmaceutical preparations and drugs; development of pharmaceutical preparations and drugs for the treatment of cancer, auto-immune diseases, and infectious diseases; development of pharmaceutical preparations and drugs in the field of immunotherapy; development of pharmaceutical preparations and drugs in the field of cell therapy; scientific research and development; scientific laboratory services; medical and scientific research
lyell lyfe manufacturing center

General Information


Serial Number90580477
Word MarkLYELL LYFE MANUFACTURING CENTER
Filing DateMonday, March 15, 2021
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, December 18, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 22, 2022

Trademark Statements


Goods and ServicesCustom manufacture of pharmaceuticals
Disclaimer with Predetermined Text"MANUFACTURING CENTER"
Goods and ServicesPharmaceutical research and development; development of pharmaceutical preparations and drugs; development of pharmaceutical preparations and drugs for the treatment of cancer, auto-immune diseases, and infectious diseases; development of pharmaceutical preparations and drugs in the field of immunotherapy; development of pharmaceutical preparations and drugs in the field of cell therapy; scientific research and development; scientific laboratory services; medical and scientific research

Classification Information


International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status Code6 - Active
Class Status DateTuesday, June 15, 2021
Primary Code040
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, June 15, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameLyell Immunopharma, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080

Party NameLyell Immunopharma, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080

Trademark Events


Event DateEvent Description
Monday, December 18, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, December 18, 2023ABANDONMENT - NO USE STATEMENT FILED
Tuesday, May 16, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, May 12, 2023SOU EXTENSION 2 GRANTED
Friday, May 12, 2023SOU EXTENSION 2 FILED
Friday, May 12, 2023SOU TEAS EXTENSION RECEIVED
Saturday, October 1, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, September 29, 2022SOU EXTENSION 1 GRANTED
Thursday, September 29, 2022SOU EXTENSION 1 FILED
Thursday, September 29, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, May 17, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 22, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 22, 2022PUBLISHED FOR OPPOSITION
Wednesday, March 2, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 15, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, February 15, 2022EXAMINER'S AMENDMENT ENTERED
Tuesday, February 15, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, February 15, 2022EXAMINERS AMENDMENT E-MAILED
Tuesday, February 15, 2022EXAMINERS AMENDMENT -WRITTEN
Thursday, October 14, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, October 14, 2021NON-FINAL ACTION E-MAILED
Thursday, October 14, 2021NON-FINAL ACTION WRITTEN
Wednesday, October 13, 2021ASSIGNED TO EXAMINER
Friday, October 1, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, October 1, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, October 1, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, June 15, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, March 18, 2021NEW APPLICATION ENTERED